{
    "Trade/Device Name(s)": [
        "FreeStyle FreedomTM Blood Glucose Monitoring System",
        "FreeStyle Freedom\u2122M Blood Glucose Monitoring System"
    ],
    "Submitter Information": "Abbott Diabetes Care Inc.",
    "510(k) Number": "K051839",
    "Predicate Device Reference 510(k) Number(s)": [
        "K992684",
        "K000582",
        "K012014",
        "K031260",
        "K050500"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW",
        "LFR"
    ],
    "Summary Letter Date": "March 9, 2006",
    "Summary Letter Received Date": "January 23, 2006",
    "Submission Date": "January 20, 2006",
    "Regulation Number(s)": [
        "21 CFR \u00a7862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Whole Blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "FreeStyle Freedom\u2122M monitor"
    ],
    "Method(s)/Technology(ies)": [
        "Coulometric biosensor",
        "Electrochemical detection",
        "Glucose dehydrogenase (GDH) enzymatic reaction"
    ],
    "Methodologies": [
        "Biosensor technology",
        "Quantitative measurement"
    ],
    "Submission Type(s)": [
        "Analyzer",
        "System"
    ],
    "Document Summary": "FDA 510(k) summary for FreeStyle Freedom Blood Glucose Monitoring System utilizing coulometric biosensor for quantitative glucose measurement in whole blood.",
    "Indications for Use Summary": "Quantitative measurement of glucose in whole blood from various body sites to aid in monitoring diabetes control, for use by healthcare professionals and people with diabetes mellitus at home; not for diagnosis/screening of diabetes, neonates, or arterial blood.",
    "fda_folder": "Clinical Chemistry"
}